Diabetes epidemiology as a tool to trigger diabetes research and care

[1]  J. Meulen.  Glucose tolerance in adults after prenatal exposure to famine , 2001, The Lancet.

[2]  S. Emmanuel,et al.  Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. , 1999, Diabetes care.

[3]  A. Rosenbloom,et al.  Emerging epidemic of type 2 diabetes in youth. , 1999, Diabetes care.

[4]  L. Groop,et al.  Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. , 1999, Diabetes.

[5]  S. Gimeno,et al.  Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group. , 1998, Diabetes care.

[6]  L. Bouter,et al.  The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study , 1998, Diabetes Care.

[7]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[8]  K. Alberti,et al.  Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[9]  P. Zimmet,et al.  New diagnostic criteria and classification of diabetes—again? , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[10]  N. Barzilai,et al.  A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.

[11]  I. Godsland,et al.  Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk , 1998 .

[12]  R. Tisch,et al.  Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. , 1998, Diabetes.

[13]  New classification and criteria for diabetes: moving the goalposts closer , 1998, The Medical journal of Australia.

[14]  J. Todd,et al.  Association of the INS VNTR with size at birth , 1998, Nature Genetics.

[15]  G. Dagenais,et al.  Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study , 1998, Diabetes Care.

[16]  A. Ziegler,et al.  Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial , 1998, Diabetologia.

[17]  M. Roden,et al.  Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro , 1998, Diabetologia.

[18]  S. O’Rahilly.  Human physiology: Life without leptin , 1998, Nature.

[19]  S. Nagataki,et al.  Onset age-dependent variations of three islet specific autoantibodies in Japanese IDDM patients. , 1998, Diabetes research and clinical practice.

[20]  P. Pozzilli,et al.  Prevention of insulin-dependent diabetes mellitus 1998. , 1998, Diabetes/metabolism reviews.

[21]  N. Ray,et al.  Economic Consequences of Diabetes Mellitus in the U.S. in 1997 , 1998, Diabetes Care.

[22]  M. Rowley,et al.  Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult‐onset diabetes mellitus , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[23]  P. Fernlund,et al.  Gender, Autoantibodies, and Obesity in Newly Diagnosed Diabetic Patients Aged 40–75 Years , 1998, Diabetes Care.

[24]  J. Tuomilehto,et al.  Is there a relationship between leptin and insulin sensitivity independent of obesity?A population-based study in the Indian Ocean nation of Mauritius , 1998, International Journal of Obesity.

[25]  A. Hattersley,et al.  Maturity‐onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[26]  A. Amos,et al.  The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[27]  P. Zimmet,et al.  Leptin inhibits insulin binding in isolated rat adipocytes. , 1997, The Journal of endocrinology.

[28]  J S Yudkin,et al.  Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study , 1997, BMJ.

[29]  P. Zimmet,et al.  Ob (obese) gene expression and leptin levels in Psammomys obesus. , 1997, Biochimica et biophysica acta.

[30]  R. Holman,et al.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes , 1997, The Lancet.

[31]  X. Pan,et al.  Prevalence of Diabetes and Its Risk Factors in China, 1994 , 1997, Diabetes Care.

[32]  C. Mantzoros,et al.  Leptin: its role in obesity and beyond , 1997, Diabetologia.

[33]  P. Zimmet,et al.  Leptin and the development of obesity and diabetes in Psammomys obesus. , 1997, Obesity research.

[34]  D. Morgan,et al.  Effects of leptin on insulin sensitivity in normal rats. , 1997, Endocrinology.

[35]  C. Newgard,et al.  β-Cell Function in Normal Rats Made Chronically Hyperleptinemic by Adenovirus-Leptin Gene Therapy , 1997, Diabetes.

[36]  M. Rowley,et al.  Autoantibodies associated with presymptomatic insulin‐dependent diabetes mellitus in women , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[37]  M. Laakso,et al.  Leptin concentrations and insulin sensitivity in normoglycemic men , 1997, International Journal of Obesity.

[38]  Terje R Pedersen,et al.  Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.

[39]  B. Howard,et al.  Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.

[40]  P. Zimmet,et al.  Hyperleptinaemia: the Missing Link in the Metabolic Syndrome? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[41]  P. Poulsen,et al.  Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs , 1997, Diabetologia.

[42]  P. Zimmet,et al.  Screening for Non‐insulin‐dependent Diabetes Mellitus: Where to Draw the Line? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[43]  L. Groop.  The molecular genetics of non‐insulin‐dependent diabetes mellitus , 1997, Journal of internal medicine.

[44]  T. Kuzuya,et al.  Classification of Diabetes on the Basis of Etiologies Versus Degree of Insulin Deficiency , 1997, Diabetes Care.

[45]  P. Zimmet,et al.  Epidemiology of NIDDM in Non-Europids , 1997 .

[46]  B. Balkau,et al.  Revision of diagnostic criteria for diabetes , 1996, The Lancet.

[47]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[48]  E. Feskens,et al.  Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey , 1996, BMJ.

[49]  P. Zimmet,et al.  Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study , 1996, BMJ.

[50]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[51]  D. Rogers,et al.  Prevention of insulin-dependent diabetes mellitus: an overview of three trials. , 1996, Cleveland Clinic journal of medicine.

[52]  M. Rowley,et al.  Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. , 1996, Diabetes research and clinical practice.

[53]  S. Klein,et al.  Relationship Between Insulin Sensitivity and Plasma Leptin Concentration in Lean and Obese Men , 1996, Diabetes.

[54]  L. Niskanen,et al.  Evolution, Risk Factors, and Prognostic Implications of Albuminuria in NIDDM , 1996, Diabetes Care.

[55]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[56]  K. Joseph,et al.  Review of the evidence on fetal and early childhood antecedents of adult chronic disease. , 1996, Epidemiologic reviews.

[57]  E. Gale,et al.  Theory and Practice of Nicotinamide Trials in Pre-Type 1 Diabetes , 1996, Journal of pediatric endocrinology & metabolism : JPEM.

[58]  L. Groop,et al.  GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosis , 1995, Diabetes Care.

[59]  J. Tuomilehto,et al.  Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius , 1995, BMJ.

[60]  M. Rowley,et al.  Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. , 1995, American journal of obstetrics and gynecology.

[61]  P. Zimmet,et al.  Prevalence and secular trends in obesity in Pacific and Indian Ocean island populations. , 1995, Obesity research.

[62]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[63]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[64]  D. Bhat,et al.  Fetal Growth and Glucose and Insulin Metabolism in Four‐year‐old Indian Children , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[65]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[66]  M. Rowley,et al.  Antibodies to glutamic acid decarboxylase and diabetes mellitus in the Multiple Risk Factor Intervention Trial. , 1994, American journal of epidemiology.

[67]  J. Nerup,et al.  Incidence of Insulin‐dependent Diabetes Mellitus in Age Groups Over 30 years in Denmark , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[68]  J. Stengård,et al.  Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.

[69]  M. Harris,et al.  Screening for NIDDM: Why is there no national program? , 1994, Diabetes Care.

[70]  M. Rowley,et al.  Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[71]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[72]  D. Nathan,et al.  Long-term complications of diabetes mellitus. , 1993, The New England journal of medicine.

[73]  M. Harris,et al.  Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.

[74]  L. Groop,et al.  Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease , 1993, Diabetes.

[75]  M. Rewers,et al.  Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults , 1993, Diabetes Care.

[76]  Å. Lernmark,et al.  Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. , 1993, The Journal of clinical investigation.

[77]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[78]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[79]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[80]  K. Hsiao,et al.  Community-Based Epidemiological Study on Diabetes in Pu-Li, Taiwan , 1992, Diabetes Care.

[81]  C Osmond,et al.  Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.

[82]  Kerin O’Dea,et al.  Westernisation, insulin resistance and diabetes in Australian Aborigines , 1991, The Medical journal of Australia.

[83]  P. Zimmet,et al.  Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[84]  S. Haffner,et al.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? , 1990, JAMA.

[85]  H. King,et al.  The epidemiology and natural history of NIDDM--lessons from the South Pacific. , 1990, Diabetes/metabolism reviews.

[86]  J. Tuomilehto,et al.  High Prevalence of NIDDM and Impaired Glucose Tolerance in Indian, Creole, and Chinese Mauritians , 1990, Diabetes.

[87]  E. Barrett-Connor,et al.  Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. , 1990, American journal of epidemiology.

[88]  P. Zimmet,et al.  An inconsistent relationship between insulin and blood pressure in three Pacific island populations. , 1990, Journal of clinical epidemiology.

[89]  P. Zimmet.  Non‐insulin‐dependent (Type 2) Diabetes Mellitus: Does It Really Exist? , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[90]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[91]  H. King,et al.  The Tasmanian Insulin‐treated Diabetes Register: Inception and progress in the first 12 months , 1986, The Medical journal of Australia.

[92]  L. Groop,et al.  Islet Cell Antibodies Identify Latent Type I Diabetes in Patients Aged 35–75 Years at Diagnosis , 1986, Diabetes.

[93]  P. Bennett,et al.  DEVELOPMENT OF RETINOPATHY AND PROTEINURIA IN RELATION TO PLASMA-GLUCOSE CONCENTRATIONS IN PIMA INDIANS , 1980, The Lancet.

[94]  P. Bennett,et al.  Gestational Diabetes: Infant and Maternal Complications of Pregnancy in Relation to Third-Trimester Glucose Tolerance in the Pima Indians , 1980, Diabetes Care.

[95]  J. Pirart.  Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973 , 1978, Diabetes Care.

[96]  K. M. West.  Epidemiology of diabetes and its vascular lesions , 1978 .

[97]  P. Bennett,et al.  Diabetes mellitus in American (Pima) Indians. , 1971, Lancet.

[98]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[99]  H. Himsworth.  DIABETES MELLITUS: ITS DIFFERENTIATION INTO INSULIN-SENSITIVE AND INSULIN-INSENSITIVE TYPES , 1936 .